The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Original Article
The Activated Partial Thromboplastin Time as a Control in Heparin Therapy
Abstract
The Lee-White clotting time as a control for heparin therapy lacks the accuracy and dependability of the prothrombin time in evaluation of Dicumerol therapy. The authors report their preliminary results of the determination of activated partial thromboplastin time for control of heparin therapy.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
